Immunoglobulin National Society (IgNS) National Conference

Healix is proud to participate with our clients in the Immunoglobulin National Society (IgNS) 10th National Conference, presenting our collaborative clinical research. Speak with presenting author Lucinda J. Van Anglen, B.S., Pharm.D., during the IgNS Poster Session on Friday, October 22, from 5:30 to 7:00 PM for a live discussion at this year’s conference.

(Poster #21) Real-World Evaluation of Immune Globulin Subcutaneous 16.5% in the Treatment of Primary Immunodeficiency: One-Year Outcomes

Lucinda J. Van Anglen, PharmD1; Jeffrey W. Langford, MD, AE-C2; Richard F. Herrscher, MD, FACAAI3; Samantha A. Mehta, PharmD1

 1Healix Infusion Therapy, LLC, Sugar Land, TX; 2Langford Allergy, LLC, Macon, GA; 3AIR Care, Dallas, TX

Immunoglobulin National Society (IgNS), 10th National Conference is live in-person and virtual, October 21-24, 2022, at the Red Rock Casino Resort & Spa, Las Vegas, Nevada. To learn more about our outcomes research and how Healix can help you establish an office infusion center or outsource the management of an existing operation contact us contact us today!

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.